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Original Article
Crosslinking and Mechanical Properties Significantly Influence
Cell Attachment, Proliferation, and Migration
Within Collagen Glycosaminoglycan Scaffolds
Matthew G. Haugh, B.A., B.A.I., Ph.D.,1,2 Ciara M. Murphy, B.Sc.,1 Ross C. McKiernan, B.Sc.,1
Cornelia Altenbuchner, M.S.,1,3 and Fergal J. O’Brien, B.A., B.A.I., Ph.D.1,2
Crosslinking and the resultant changes in mechanical properties have been shown to influence cellular activity
within collagen biomaterials. With this in mind, we sought to determine the effects of crosslinking on both the
compressive modulus of collagen-glycosaminoglycan scaffolds and the activity of osteoblasts seeded within
them. Dehydrothermal, 1-ethyl-3-3-dimethyl aminopropyl carbodiimide and glutaraldehyde crosslinking
treatments were first investigated for their effect on the compressive modulus of the scaffolds. After this, the
most promising treatments were used to study the effects of crosslinking on cellular attachment, proliferation,
and infiltration. Our experiments have demonstrated that a wide range of scaffold compressive moduli can be
attained by varying the parameters of the crosslinking treatments. 1-Ethyl-3-3-dimethyl aminopropyl carbo-
diimide and glutaraldehyde treatments produced the stiffest scaffolds (fourfold increase when compared to
dehydrothermal crosslinking). When cells were seeded onto the scaffolds, the stiffest scaffolds also showed
increased cell number and enhanced cellular distribution when compared to the other groups. Taken together,
these results indicate that crosslinking can be used to produce collagen–glycosaminoglycan scaffolds with a
range of compressive moduli, and that increased stiffness enhances cellular activity within the scaffolds.
Introduction
Collagen–glycosaminoglycan (CG) scaffolds wereoriginally developed for skin regeneration and have
since shown great potential in many areas of tissue engi-
neering, including nerve, cartilage, and bone.1–7 Collagen is
particularly attractive for tissue engineering due to its ex-
cellent biocompatibility, degradation into physiological
end-products, and suitable interaction with cells and other
macromolecules.8 Despite these advantages, the relatively
weak mechanical properties of collagen may limit their use
as a scaffold. Mechanical properties are an important factor
when designing a scaffold for use in tissue engineering, as
the scaffold must have suitable characteristics to facilitate
in vitro handling and withstand the in vivo environment. In
addition, there is a growing body of work demonstrating
how the stiffness of a scaffold can direct cellular activity such
as attachment and differentiation.9–12 Thus, scaffold stiffness
can further determine the functionality of a tissue-engineered
construct through mechano-transductive pathways. Cross-
linking is a technique that is often used to enhance the me-
chanical properties of collagen-based biomaterials by
forming bonds between collagen molecules.13–15 These bonds
strengthen collagen fibers by preventing the long rod-like
molecules from sliding past each other under stress.16 Due to
the interaction between mechanical properties and biological
activity, it is of interest to determine the effects of cross-
linking treatments on both the mechanical properties of
collagen scaffolds and the activity of cells within the cross-
linked scaffolds.
Crosslinking treatments can be split into two main groups:
chemical crosslinking and biophysical crosslinking. Ex-
amples of chemical methods include the use of glutaralde-
hyde (GTA) and various carbodiimides, whereas biophysical
methods include the use of UV light and dehydrothermal
(DHT) crosslinking. DHT treatment involves subjecting col-
lagen to increased temperature (>988C) while under vac-
uum. This removes water from the collagen molecules,
resulting in the formation of intermolecular crosslinks
through condensation reactions (Fig. 1). An advantage of
DHT crosslinking is that it does not involve the use of cy-
totoxic reagents. 1-Ethyl-3-3-dimethyl aminopropyl carbo-
diimide (EDAC) and GTA are two of the most commonly
used chemical crosslinking agents. These two chemicals
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work in distinctly different fashions. EDAC forms ‘‘zero
length’’ crosslinks, which are chemically identical to those
formed during DHT treatment, whereas GTA crosslinks take
the form of long polymer chains (Fig. 1).14,17 This means that
EDAC is limited to crosslinking collagen molecules that are
directly adjacent to each other (1 nm), whereas GTA can
crosslink molecules that are separated by a distance.18 The
nature of this chemical crosslinking involves the use of re-
agents that have the potential to cause cell death if they re-
main within the scaffold. It is therefore necessary to carry out
experiments to determine if these chemicals have any cyto-
toxic side effects. EDAC crosslinking does not attach any
harmful molecules to the scaffold, but it does need to be
thoroughly washed out of the scaffolds before use as the
chemical itself is toxic, as is urea, which is the by-product of
the crosslinking reaction.17 GTA has the potential to leach
out of the scaffold as it degrades, with potentially toxic re-
percussions for cells in the immediate area,19,20 although
there is some debate as to whether it is cytotoxic on a clini-
cally relevant level.15,21,22
Despite the widespread use of crosslinking treatments on
collagen films, fibers, and scaffolds, a detailed analysis has
not been carried out to determine how the process variables
affect CG scaffold properties. Previous studies have con-
centrated on optimizing the effectiveness of individual
crosslinking treatments,15,17,21,23 but a study directly com-
paring the effectiveness of several grades of different treat-
ments has yet to be carried out. Additionally, many studies
have investigated crosslinking of collagen fibers or films that
may not be directly comparably to the crosslinking of a CG
scaffold.13,23–25 Likewise, knowledge of the effect of cross-
linking on the activity of cells seeded onto collagen scaffolds
is incomplete.
The overall goal of this study was to determine the effects
of crosslinking and the resulting changes in compressive
modulus on cellular activity within CG scaffolds. Compres-
sive testing was used to characterize the effect of crosslinking
on mechanical properties as it allows comparison of the re-
sults to several previous studies15,26,27; additionally, com-
pressive modulus has been shown to be the most relevant
property when investigating cellular response to substrate
properties.10,27 Based upon the results of the compressive
testing, several groups were carried forward for cellular ex-
periments. DHT treatment at 1058C for 24 h was chosen as a
control, as it is the standard crosslinking treatment used in
many studies.2,28,29 The scaffolds were seeded with an
MC3T3 osteoblastic cell line, which has been used in several
studies in our laboratory, thus allowing comparison to pre-
vious work.28–31 The specific goals of this study were to in-
vestigate the effects of the crosslinking treatments on scaffold
stiffness and then the seeding efficiency, proliferation, and
spatial distribution of MC3T3-E1 pre-osteoblasts seeded onto
CG scaffolds.
Materials and Methods
Scaffold fabrication
Scaffolds were produced by freeze-drying a CG suspen-
sion as described previously.32 Briefly, a suspension con-
taining 0.5% (w/v) collagen (Integra Life sciences) and
0.044% (w/v) chondroitin-6-sulfate (Sigma-Aldrich) was
prepared in 0.05M acetic acid. This slurry was then freeze-
dried using a freezing temperature of 408C. This process
produces a highly porous sheet of CG scaffold, with an av-
erage pore size of 120mm.32
Crosslinking
After freeze-drying cylindrical samples (Mechanical test-
ing: 8mm diameter4mm height; Cell culture: 12.7mm
diameter4mm height) were cut from the scaffold sheet.
DHT treatment was carried out by placing the samples in an
FIG. 1. The structure and crosslinking mechanisms of the
treatments used in this study. (A) DHT treatment results in
crosslink formation between adjacent carboxylic and amine
groups through a condensation reaction. (B) EDAC and N-
hydroxysuccinimide (NHS) catalyze a reaction between ad-
jacent carboxylic and amine groups to form crosslinks. EDAC
first activates a carboxylic group, which then reacts with NHS
to produce an NHS-activated carboxylic acid group and urea.
Finally, the NHS-activated carboxylic acid group reacts with a
free amine group to produce a crosslink. (C) GTA forms long
polymer chains that react with amine groups to form cross-
links. DHT, dehydrothermal; EDAC, 1-ethyl-3-3-dimethyl
aminopropyl carbodiimide; GTA, glutaraldehyde.
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aluminium foil packet inside a vacuum oven (Vacucell 22;
MMM) under a vacuum of 0.05 bar. To determine the effect
of DHT parameters on scaffold performance, four different
crosslinking temperatures were used: 1058C, 1208C, 1508C,
and 1808C. To determine the effect of EDAC crosslinking,
five different concentrations of EDAC (Sigma-Aldrich, Ger-
many) were used: 0.6, 3, 6, 48, and 96mM EDAC per gram
CG scaffold. These concentrations were prepared in 2mL of
sterile distilled water and the samples were crosslinked in
24-well plates for 24 h. N-Hydroxysuccinimide (NHS) is a
catalyst that is commonly used with EDAC; a molar ratio of
2.5M EDAC/M N-hydroxysuccinimide was used for all
EDAC crosslinking.24 GTA (Sigma-Aldrich) crosslinking was
also carried out using five concentrations: 0.25, 0.5, 1.25, 2.5,
and 3.75mM GTA per gram of CG scaffold. GTA cross-
linking solutions were prepared in phosphate-buffered saline
(PBS) and the samples were crosslinked in 24-well plates for
24 h. After crosslinking the scaffolds were washed twice us-
ing sterile PBS (Sigma-Aldrich). The concentrations of EDAC
and GTA are expressed relative to a gram of collagen
throughout this article.
Mechanical testing
Compressive testing was used to determine the effect of
crosslinking on the modulus of the scaffolds. Mechanical
testing of scaffold samples was carried out using a me-
chanical testing machine (Z050; Zwick/Roell) fitted with a
5-N load cell. Samples were prehydrated in PBS for 1 h be-
fore testing and all testing was carried out in a bath of PBS.
For unconfined compression testing with impermeable,
un-lubricated platens, samples of 8mm diameter (n¼ 10 per
group) were cut from the scaffolds using a punch. Testing
was conducted at a strain rate of 10%/min. The modulus
was defined as the slope of a linear fit to the stress–strain
curve over 2%–5% strain.26
Cell culture
MC3T3-E1 preosteoblasts (ATCC) were cultured in T175
culture flasks (Sarstedt) using a-minimum essential media
(Sigma-Aldrich) supplemented with 10% fetal bovine serum
(BioSera), 1% L-glutamine (Sigma-Aldrich), and 2% penicillin/
streptomycin (Sigma-Aldrich). Before seeding, cells (Passage
26) were detached using trypsin–ethylenediaminetetraacetic
acid (Sigma-Aldrich) and suspended in supplemented me-
dium at 107 cells/mL. Crosslinked scaffolds were placed into
6-well tissue culture plates (Sarstedt). The top surface of each
of the scaffolds was then seeded with 100 mL of the cell
suspension (1106 cells). The six-well plates were then
placed in an incubator for 15min to allow initial cellular
attachment. The scaffolds were then turned over and the
opposite surface was seeded with 100 mL of the cell suspen-
sion and incubated for a further 15min. After the second
incubation period, 5mL of supplemented medium was ad-
ded to each well and the plates were returned to the incu-
bator. Both culture flasks and seeded scaffolds were cultured
under standard conditions (378C, 5% CO2).
Hoechst DNA assay
Cell number was evaluated using the Hoechst 33258 DNA
assay, which fluorescently labels double-stranded DNA
(Sigma-Aldrich), according to a previously published pro-
tocol.33 After 1, 2, and 7 days of incubation, seeded scaffolds
(n¼ 3 per group) were washed twice using PBS to remove
un-adheared cells before being flash-frozen in liquid nitrogen
and stored at 808C. Samples were then thawed and di-
gested in papain (Sigma-Aldrich) for 1.5 h at 608C. Hoechst
dye solution was then added to the digested samples and
210mL was then plated, in triplicate, into a 96-well plate.
Fluorescence was then measured (excitation: 355 nm; emis-
sion: 460 nm) using a fluorescence spectrophotometer
(Wallac Victor2; PerkinElmer Life Sciences). Readings were
converted to cell number using a standard curve, with un-
seeded scaffolds used as blanks.
Histology
Histological analysis was used to evaluate the spatial
distribution of cells within the scaffolds. After 1, 2, and 7
days of incubation, scaffold samples were placed into a so-
lution of 10% formalin for 30min and then embedded in
paraffin wax using an automatic tissue processor (ASP300;
Leica). All samples were sectioned longitudinally at a
thickness of 10 mm throughout the depth of the sample using
a rotary microtome (Leica microtome; Leica). Sections were
mounted on slides and stained using hematoxylin and eosin
to evaluate spatial distribution of cells within each of the
scaffolds. Digital images were recorded using a microscope
(Optimphot2; Nikon).
Statistical analysis
Results are expressed in the figures as mean standard
deviation. One-way analysis of variance followed by pair-
wise multiple comparison procedures (Tukey test) was used
to evaluate the effects of crosslinking on both the compres-
sive modulus of CG scaffolds and cellular attachment. Sta-
tistical significance was declared at p 0.05.
Results
Effect of crosslinking on compressive modulus
Increasing the temperature of DHT treatment was found
to result in an increase in the mechanical properties. Com-
pressive modulus increased twofold for scaffolds crosslinked
at 1808C compared with that at 1058C ( p< 0.001; Fig. 2A).
However, as significant denaturation has been previously
observed at 1808C using Fourier transform infrared micros-
copy26 and crosslinking at 1508C produced a 1.9-fold in-
crease in modulus, the scaffolds carried forward to the
cellular attachment experiments were crosslinked at 1508C.
Analysis of the mechanical testing after EDAC treatment
revealed that compressive modulus increased with increas-
ing EDAC concentration ( p< 0.05; Fig. 2B). A concentration
of 96mM EDAC produced the stiffest scaffolds, with a
compressive modulus of 1.8 kPa, representing a fourfold in-
crease in modulus over the untreated scaffolds ( p< 0.05).
However, a concentration of 6mM EDAC produced a simi-
larly significant increase in modulus when using one 16th the
amount of EDAC. Therefore, both concentrations were used
in the cellular attachment study, 96mM as it produced the
stiffest scaffolds and 6mM as it was the most efficient
treatment. Analysis of the mechanical testing after GTA
treatment revealed that compressive modulus increased with
CROSSLINKING AND MECHANICAL PROPERTIES 3
concentration up to 1.25mM GTA ( p< 0.05; Fig. 2C). Further
increases gave insignificant changes in modulus, with a re-
duction in modulus comparing 3.75mM GTA to 1.25mM
GTA ( p> 0.05). GTA crosslinking using 1.25mM produced
the stiffest scaffolds, with a compressive modulus of
1.45 kPa. This was a threefold increase over the untreated
scaffolds ( p< 0.05), and consequently this concentration was
used in the cellular attachment study.
Effect of crosslinking on cell number
within CG scaffolds
The number of cells within the scaffolds was found to vary
with the method of crosslinking used (Fig. 3A). The 6mM
EDAC and 1.25mM GTA groups showed a significant in-
crease in cell number over the standard, DHT 1058C-treated
scaffolds at all time points ( p< 0.05). In particular, GTA-
crosslinked scaffolds had a significantly higher cell number
than all other treatment groups, showing a fivefold increase
in cell number compared to the standard DHT 1058C-
crosslinked scaffolds ( p< 0.001).
Initial cell adhesion to CG scaffolds and proliferation
To better interpret the data, the effect of crosslinking on
seeding efficiency was measured by expressing the number
of cells attached after 1 day as a percentage of the number of
cells initially seeded (2106 cells, Fig. 3B). The GTA-treated
group had the highest seeding efficiency, with 70% of seeded
cells attached after 1 day. This represents a 4.5-fold increase
FIG. 2. The effect of various crosslinking treatments on the
compressive modulus of the scaffolds (A) DHT, (B) EDAC,
and (C) GTA. N¼ 10 samples per group, ap< 0.05 relative to
1058C, bp< 0.05 relative to 0mM EDAC, cp< 0.05 relative to
all other groups, dp< 0.05 relative to 0 g GTA, and ep< 0.05
relative to 0.05 g GTA. CG, collagen-glycosaminoglycan.
FIG. 3. The effect of crosslinking on (A) cell number within
the scaffold at days 1, 2 and 7, (B) cell number at day 1
expressed as a percentage of seeded cell number, and (C)
proliferation within the scaffolds as measured by subtracting
the cell number at day 1 from the cell number at day 7. N¼ 3
per group, ap< 0.05 relative to 1058C, bp< 0.05 relative to all
other groups, and cp< 0.05 significant change in cell number
between days 1 and 7.
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over the DHT 1058C treatment ( p< 0.001). Cellular prolif-
eration upon the scaffolds was measured using the difference
between the cell number at 1 and 7 days (Fig. 3C). Significant
levels of proliferation were found in both the 6mM EDAC
and GTA crosslinking groups ( p< 0.05). In particular, a
twofold increase in cell number was found in the GTA-
crosslinked group ( p< 0.001). A nonstatistically significant
reduction in cell number was found in the 96mM EDAC-
crosslinked group.
Cell infiltration
Histology was used to determine the effect of crosslinking
on the spatial distribution of cells within the CG scaffolds at
1, 2, and 7 days. Sections at the day 7 time point are shown in
Figure 4 to illustrate the differences in cellular infiltration
between the groups. As the sections from the DHT 1508C
and 96mM EDAC groups were similar to the DHT 1058C
group, they have been omitted. All treatment groups show
cellular attachment at the edge of the scaffolds at 1 and 7
days. There was no evidence of cellular infiltration into the
center of the scaffolds after 7 days in the DHT (Fig. 4B) and
96mM EDAC groups (not shown). However, both the 6mM
EDAC and GTA crosslinking groups show notable levels of
cellular infiltration at the center of the scaffolds after 7 days
of culture (Fig. 4D, F); this was more pronounced in the GTA
group.
Discussion
The aim of this study was to develop a series of CG
scaffolds with a range of compressive moduli and to deter-
mine the effects of compressive modulus on cellular behav-
ior. We used osteoblasts for cellular characterization as we
have a specific interest in scaffolds for bone repair; however,
the results obtained have led to the production of a series of
characterized scaffold variants that can be adapted for other
tissue engineering applications or used to expand our un-
derstanding of the interactions between scaffold properties
and cellular activity. Our experiments have demonstrated
that a wide range of compressive moduli can be attained by
varying the parameters of the crosslinking treatments
(Fig. 2). The stiffest scaffolds were produced using 96mM
EDAC and 1.25mM GTA, which had compressive moduli of
1.8 kPa and 1.4 kPa, respectively. When cells were seeded
onto the scaffolds, the 6mM EDAC and 1.25mM GTA-
crosslinked scaffolds showed increased cell number and en-
hanced cellular distribution when compared to the other
crosslinking treatments (Figs. 3 and 4). Taken together, these
results indicate that crosslinking can be used effectively to
produce CG scaffolds with a range of compressive moduli,
and that increased stiffness enhances cellular activity within
the scaffolds.
The methods used in this study specify the effects of
several crosslinking treatments at a range of different
FIG. 4. Effect of crosslinking on
cell infiltration and distribution
within CG scaffolds after 7 days.
Scaffolds were stained with hema-
toxylin and eosin: (A) edge of DHT
1058C, (B) center of DHT 1058C, (C)
edge of EDAC 6mM, (D) center of
EDAC 6mM, (E) edge of GTA
0.125 g, and (F) center of the GTA
0.125 g. Collagen scaffold is stained
pink and cell nuclei a deep purple.
Infiltration of cells into the center of
the scaffolds and increased cell
number can be seen in the stiffer
EDAC- and GTA-crosslinked
groups. Color images available
online at www.liebertonline
.com/ten.
CROSSLINKING AND MECHANICAL PROPERTIES 5
concentrations that can be directly related to the collagen
content of the scaffolds. The majority of the work previously
published has neglected to give the molar ratios of the
crosslinking agents to the weight of collagen treated,15,17,34,35
preventing the results from being used in an effective man-
ner as the exact crosslinking conditions cannot be re-
produced. This information is particularly useful when the
relationship between cytotoxicity and the concentration of a
crosslinking agent is of interest. In this study we use com-
pressive testing to determine the effects of crosslinking upon
mechanical properties, whereas several studies use tensile
testing.13,35,36 However, previous work has shown that the
compressive properties are of greatest interest when study-
ing the effects of substrate properties on cellular activity such
as cell-mediated contraction, attachment, and differentia-
tion.10,27 Taking into account these studies and the material
demands of tensile testing, it was decided that compressive
testing would provide sufficient data for mechanical char-
acterization of the crosslinked scaffolds.
Harley et al. also examined the effectiveness of EDAC
crosslinking of CG scaffolds and reported a compressive
modulus of 1.497 kPa when treating scaffolds with 6mM
EDAC.27 This compares well with our result of 1.442 kPa
with scaffolds crosslinked at the same molar ratio. While
Olde Damink et al. reported that the optimal increase in
shrinkage temperature and crosslinks formed was achieved
using 6mM of EDAC per gram of collagen, our results show
the highest compressive modulus at 96mM.24 EDAC forms
crosslinks between carboxylic and amine groups (Fig. 1),
which are present in the scaffolds at concentrations of
1.264mM and 0.312mM per gram of CG scaffold, respec-
tively.24,37 The maximum number of crosslinks is therefore
limited by the amine group content. However, due to the
close positional alignment needed for EDAC crosslinking it
may be required to activate all the carboxylic groups present
to complete crosslinking. Therefore, a concentration of
1.264mM EDAC would be required to form the theoretical
maximum number of crosslinks. Our results show that
96mM EDAC produced the maximum compressive modu-
lus; the difference between this amount and the maximum
theoretical concentration required may be explained by the
fact that EDAC has been observed to react with the urea
formed as a by product of the crosslinking reaction.38 This
reaction with urea may also explain the reduction in the ef-
ficiency of the crosslinking reaction above 6mM. GTA forms
crosslinks between two amide groups (Fig. 1), and this
would limit the theoretical maximum number of crosslinks
to 0.156mM per gram of CG scaffold.14 However, as GTA
has the ability to form polymer chains, estimation of the
theoretical concentration of GTA needed to form the maxi-
mum number of crosslinks and the modulus of GTA treated
CG scaffolds, while of interest, would be beyond the scope of
this study.
The most favorable modulus was attained using 96mM
EDAC and 1.25mM GTA. Crosslinking using these treat-
ments resulted in a three- to fourfold increase in compressive
modulus (Fig. 2B, C). In addition, 6mM EDAC crosslinking
imparted a modulus comparable to the 96mM EDAC group
while making efficient use of the crosslinking reagent (4/5ths
of the highest modulus was attained using 1/16th the
amount of EDAC), this proved to be of importance when
the cytotoxicity of the treatment was evaluated. The 6mM
EDAC and 1.25mM GTA treatment groups show enhanced
seeding efficiency, proliferation, and infiltration (Figs. 3 and
4). In particular, GTA-crosslinked scaffolds showed a 6.4-fold
increase in cell number at 7 days when compared to the
standard DHT 1058C group. Additionally, the proliferation
data correlate with infiltration as the 6mM EDAC and
1.25mM GTA groups are the only groups to show infiltra-
tion into the center of the scaffolds after 7 days. The differ-
ence in the proliferation between the 6mM EDAC group and
the 1.25mM GTA group is likely to be a result of higher cell
number at day 1 due to superior seeding efficiency.
Examining the data from the cellular attachment within the
DHT-treated scaffolds, we report a 15% seeding efficiency at
24 h upon the standard scaffolds compared to 40% reported
by O’Brien et al.29 However, the scaffolds in the O’Brien
study were seeded dry, which would aid infiltration as the
cell suspension would not have to displace any fluid already
within the scaffolds. The DHT-treated scaffolds in this study
were seeded in a hydrated state to enable a direct compari-
son to chemical treatments that required the scaffolds to be
hydrated at the seeding stage. This limitation could have
been overcome through freeze-drying the chemically cross-
linked scaffolds to dry them, though it is likely that this
would have caused some damage to the structure of the
scaffolds.
Previous work has postulated that cell-mediated contrac-
tion may reduce proliferation of chondrocytes.15 In this
study, the only groups observed to show any cell-mediated
contraction were the groups treated using DHT treatment.
Therefore, the lack of proliferation in these groups may be
caused by contraction of the scaffold structure, which among
other things causes a collapse of the scaffold pore structure
reducing the diffusion of nutrients and waste products
within the scaffold. The increased modulus of GTA and
EDAC-crosslinked scaffolds enabled them to retain their
porous structure, allowing proliferation and infiltration
within these groups. Further, cells have been shown to have
the capability to react to the mechanical properties of the
material to which they are attached.9,10 This has been pos-
tulated to be related to the tension or pull generated through
actomyosin filaments acting through the integrin-actin cou-
pling at focal adhesion complexes.39,40 Further adding to this
hypothesis, Engler et al. have shown that nonmuscle myosin
plays a role in the sensitivity of cells to substrate stiffness.10
Thus, the mechanical properties of the scaffolds may influ-
ence cellular attachment and proliferation through mechano-
transductive pathways in addition to their effect on physical
parameters caused by the retention of pore architecture.
However, one caveat to note is that although the 1.25mM
GTA and 6mM EDAC-crosslinked scaffolds have compara-
ble moduli, the GTA-crosslinked scaffolds show superior
seeding efficiency. This suggests that the presence of GTA
crosslinks, in some way, positively influences seeding and
cellular attachment. Crosslinking consumes hydrophilic
amino groups and therefore causes a reduction in collagen
hydrophilicity. Previous studies have shown that EDAC
causes a larger reduction in the hydrophilic nature of colla-
gen films compared to GTA.25 Any increase in scaffold hy-
drophobicity might reduce the volume of cell suspension
retained within the scaffold during seeding, thus potentially
explaining the poorer cellular retention in the EDAC-treated
in comparison to the GTA-treated groups.
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The 96mM EDAC group did not perform as well as the
other chemical crosslinking groups, showing a reduction in
cell number after 7 days. This may be evidence of the cyto-
toxic effects of EDAC at high concentrations. Although
EDAC is not incorporated into the scaffold when it forms
crosslinks, the by-product of this reaction is urea, which is
cytotoxic if left within the scaffolds. Previous work has found
a reduction in cellular activity when high concentrations of
EDAC are used to crosslink collagen scaffolds.17 The authors
postulated that it becomes more difficult to wash out the
resultant urea and unused EDAC when high concentrations
of EDAC are used. We found no evidence of cytotoxicity
caused by GTA crosslinking. GTA is integrated into the
crosslinks that are formed, and un-reacted GTA may also
remain within the scaffold after crosslinking. Previous
studies have found some evidence of cytotoxicity, causing
reduced proliferation, with cells cultured on GTA-cross-
linked CG scaffolds.15 Contrary to this, we found an increase
in cellular activity with GTA-crosslinked scaffolds. However,
there is still the potential for damage to the cells to occur as
GTA is released while the scaffold degrades, although some
in vivo studies show no evidence of adverse effects.21 In the
context of bone tissue engineering, there are differing reports
in the literature on the relationship between GTA cross-
linking and mineralization. GTA crosslinking has been
shown in some studies to induce calcification in vivo.34,41
However, there are reports that GTA may also compromise
mineralization in CG scaffolds.22 Long-term cell culture ex-
periments in osteogenic media are needed to clarify these
findings.
Conclusion
When considering a crosslinking method for scaffolds
used in a particular tissue engineering application, the effects
of the various treatments on cellular activity are just as im-
portant as the effects on mechanical properties. The results of
this study show that EDAC and GTA crosslinking can be
used to substantially improve the compressive modulus of
CG scaffolds and that cellular activity within the scaffolds
was enhanced as a result of the increased stiffness produced
through crosslinking. GTA-crosslinked scaffolds show the
greatest potential for tissue engineering, despite not posses-
sing the highest compressive modulus, having the ability
to support 6.4 times as many cells as the standard DHT-
crosslinked scaffolds ( p< 0.05). The enhanced cellular
activity upon GTA- and EDAC-treated scaffolds, coupled
with improved compressive stiffness, increases their suit-
ability for use both in vitro and in vivo.
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